Maturing in one year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One GSK Agreement GSK Agreement [Member] GSK Agreement Investments in other-than-temporary decline in fair value Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Related Party Transactions [Abstract] Related Party Transactions [Abstract] Total principal payments and final fee Long-Term Debt, Gross Entity Address, Postal Zip Code Entity Address, Postal Zip Code Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding 2025 Long-Term Debt, Maturity, Year Two Debt Instrument [Axis] Debt Instrument [Axis] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Upfront, milestone, and option purchase payments, aggregate amount Contract With Customer, Upfront Payments, Milestone Payments, Option Purchase Payments, Aggregate Amount Contract With Customer, Upfront Payments, Milestone Payments, Option Purchase Payments, Aggregate Amount Non-Employees Non Employees [Member] Non-employees. Financial Instruments [Domain] Financial Instruments [Domain] Debt instrument variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Statistical Measurement [Domain] Statistical Measurement [Domain] Debt instrument, term, prepayment amount Debt Instrument, Term, Prepayment Amount Debt Instrument, Term, Prepayment Amount Issuance of common stock upon exercise of stock options (in shares) Number of Shares, exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Interest rate percentage Debt Instrument, Interest Rate, Stated Percentage Proceeds from sales or maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Weighted average shares excluded from computation of diluted net income per share attributable to common stockholders (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Maturing after one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Schedule of Future Principal Debt Payments on the Loan Payable Schedule of Maturities of Long-Term Debt [Table Text Block] Equity Component [Domain] Equity Component [Domain] Assets measured on recurring basis Assets, Fair Value Disclosure Vesting period percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Leases Lessee, Operating Leases [Text Block] Operating expenses and capital expenditure requirements (in months) Funding Term Of Borrowings For Operating Expenses And Capital Expenditure Requirements Commitment date stock price (in dollars per share) Debt Instrument Commitment Date Stock Price Debt Instrument commitment date stock price. Lease Agreements [Line Items] Lessee, Lease, Description [Line Items] Related Party [Domain] Related Party [Domain] Plan Name [Axis] Plan Name [Axis] Fair Value Marketable securities Debt Securities, Available-for-Sale Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Weighted Average Exercise Price, Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Plan Name [Domain] Plan Name [Domain] First $500 Converted at $1.56 per share First $500,000 Converted at $1.56 per share [Member] First $500,000 Converted at $1.56 per share Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Outstanding term loan principal balance Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Shares issuable upon conversion of convertible notes, as if converted (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Final fee due at maturity in 2025 Debt Instrument Final Fee Amount Due At Maturity Debt instrument final fee amount due at maturity in two thousand and twenty four. 2018 Employee Stock Purchase Plan Employee Stock [Member] Accrued expenses and other current liabilities Accrued Liabilities And Other Liabilities Current Accrued liabilities and other liabilities current. Weighted Average Remaining Contractual Term (in years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Axis] Award Type [Axis] Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Operating lease liability Operating Lease, Liability, Current Summary of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Summary of Fair Value of Available-for-sale Marketable Debt Securities by Type of Security Debt Securities, Available-for-Sale [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Contract with customer, expiration period Contract with Customer, Expiration Period Contract with Customer, Expiration Period Lender Name [Axis] Lender Name [Axis] Number of Shares, forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Note payable Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Net amortization of premiums and discounts on marketable securities Investment Income, Net, Amortization of Discount and Premium Issuance of common stock upon public offering, net of issuance costs Stock Issued During Period, Value, New Issues Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Marketable securities Debt Securities, Available-for-Sale, Current Preferred stock, issued (in shares) Preferred stock shares issued to related party (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Transferred at Point in Time Transferred at Point in Time [Member] Weighted Average Grant-Date Fair Value, beginning balance (in dollars per share) Weighted Average Grant-Date Fair Value, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities 2014 Plan Two Thousand Fourteen Stock Incentive Plan [Member] Two Thousand Fourteen Stock Incentive Plan. Financial Instrument [Axis] Financial Instrument [Axis] Term Loans Term Loans [Member] Term loans. 2018 Stock Option and Incentive Plan Two Thousand Eighteen Stock Option And Incentive Plan [Member] Two thousand eighteen stock option and incentive plan. Document Period End Date Document Period End Date Vesting August 2022 Share-Based Payment Arrangement, Tranche One [Member] Transaction price Contract With Customer, Transaction Price Contract With Customer, Transaction Price Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Total assets Assets Payment for reimbursement of manufacturing costs incurred Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities Antidilutive Securities [Axis] Sublease Agreement with EQRx Sublease Agreement With E Q Rx [Member] Sublease agreement with EQRx. Schedule of Future Undiscounted Cash Inflows Under Sublease Lessee Operating Sublease Liability Maturity Table [Table Text Block] Lessee operating sublease liability maturity. Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Weighted Average Exercise Price, Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Interest expense Interest Expense, Debt Novartis Collaboration Novartis Collaboration [Member] Novartis collaboration. Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Net Income (Loss) per Share Earnings Per Share [Text Block] Maturing after one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Marketable securities tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Operating lease liability Increase (Decrease) in Operating Lease Liability Related Party Transaction [Line Items] Related Party Transaction [Line Items] Award Type [Domain] Award Type [Domain] Grantee Status [Axis] Grantee Status [Axis] Unrecognized stock-based compensation cost, weighted-average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted Average Remaining Contractual Term (in years), Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Proceeds from employee stock purchases Proceeds from Stock Plans 2014 Plan and 2018 Plan Two Thousand Fourteen And Eighteen Stock Incentive Plan [Member] Two thousand fourteen and eighteen stock incentive plan. Entity Registrant Name Entity Registrant Name Issuance of common stock upon public offering, net of issuance costs (in shares) Common stock, issued (in shares) Stock Issued During Period, Shares, New Issues Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Entity Address, City or Town Entity Address, City or Town Number of potential tranches Number Of Potential Tranches Number of potential tranches. Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract] Leases [Abstract] Leases [Abstract] Operating expenses: Operating Expenses [Abstract] Granted to Employee Share-Based Payment Arrangement, Employee [Member] Revenue Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Minimum Minimum [Member] Maturing in one year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share 2021 ATM Facility 2021 ATM Facility [Member] 2021 ATM Facility Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value of Financial Assets Fair Value Disclosures [Text Block] Share price (in dollars per share) Share Price Trading Symbol Trading Symbol Entity File Number Entity File Number Shares available from conversion of note payable Convertible Debt Securities [Member] Research and development Research and Development Expense Title of Individual [Axis] Title of Individual [Axis] Unvested restricted stock units, Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period RSU’s issued and expected to vest Restricted Stock Units (RSUs) [Member] Number of Shares, vested and expected to vest at June 30, 2022 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Default interest rate (as a percent) Annual Default Interest Rate Percentage Annual default interest rate percentage. Accounts payable Increase (Decrease) in Accounts Payable Unamortized debt discount and final fee Debt Instrument Unamortized Debt Discount And Final Fee Debt instrument unamortized debt discount and final fee. Number of positions, 12 months or longer Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Marketable Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Income Taxes Income Tax Disclosure [Text Block] Development Milestone Development Milestone [Member] Development Milestone Credit Facility [Domain] Credit Facility [Domain] Aggregate fair value, securities, 12 months or longer Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Fair Value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Net income (loss) per share — basic (in dollars per share) Earnings Per Share, Basic Potential milestones payment Potential Milestones Payment Potential milestones payment. Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Cash and cash equivalents and restricted cash at beginning of period Cash and cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Weighted Average Grant-Date Fair Value, Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Vesting [Domain] Vesting [Domain] Sales Milestone Payment Sales Milestone Payment [Member] Sales Milestone Payment Entity Interactive Data Current Entity Interactive Data Current Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Additional right-of-use asset and related lease liability Additional Right Of Use Asset And Related Lease Liability Additional right of use asset and related lease liability. Dilutive effect of common stock equivalents (shares) Incremental Common Shares Attributable to Dilutive Effect of Common Stock Equivalents Incremental Common Shares Attributable to Dilutive Effect of Common Stock Equivalents Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Money market funds Money Market Funds [Member] Accumulated Deficit Retained Earnings [Member] Unrecognized stock-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Dividends, declared or paid Dividends, Common Stock, Cash Common Stock Common Stock [Member] Summary of Stock-Based Compensation Expense Related to Stock Options and Restricted Stock Awards Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Number of shares available for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Fee due in 2023 Debt Instrument Final Fee Amount Due in 2023 Debt Instrument Final Fee Amount Due in 2023 Prepayment penalty fee percentage (as a percent) Prepayment Penalty Fee Percentage Prepayment penalty fee percentage. Number of option targets Revenue, Performance Obligation, Number of Targets Revenue, Performance Obligation, Number of Targets Statement [Table] Statement [Table] Effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Weighted Average Grant-Date Fair Value, Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Document Quarterly Report Document Quarterly Report Current assets: Assets, Current [Abstract] Operating lease liability, non-current Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Grantee Status [Domain] Grantee Status [Domain] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Purchases of marketable securities Payments to Acquire Marketable Securities Equity Components [Axis] Equity Components [Axis] Proceeds from issuance of private placement Proceeds from Issuance of Private Placement Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Weighted Average Exercise Price, Exercisable at June 30, 2022 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Related Party Transactions Related Party Transactions Disclosure [Text Block] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Aggregate fair value, securities, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Unvested restricted stock units, beginning balance (in shares) Unvested restricted stock units, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Operating lease right-of-use asset Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Weighted Average Exercise Price, Vested and expected to vest at June 30, 2022 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report Local Phone Number Local Phone Number Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Income (loss) from operations Operating Income (Loss) Convertible note payable Convertible Notes Payable, Current Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Number of shares issued upon conversion of term loan (in shares) Debt Conversion, Converted Instrument, Shares Issued Prepayment Occurs More than Thirty Six Months after Initial Funding Date Prepayment Occurs More Than Thirty Six Months After Initial Funding Date [Member] Prepayment occurs more than thirty six months after initial funding date. Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Adjustments to reconcile net income (loss) to net cash provided by (used in)    operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax provision or benefit Income Tax Expense (Benefit) Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Number of Shares, granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Basic net income (loss) per share: Earnings Per Share, Basic [Abstract] Restricted cash Restricted Cash, Noncurrent Weighted average common shares outstanding— diluted (in shares) Weighted average common shares outstanding—diluted (shares) Weighted Average Number of Shares Outstanding, Diluted 2018 Employee Stock Option and Incentive Plan Two Thousand Eighteen Employee Stock Purchase Plan [Member] Two thousand eighteen employee stock purchase plan. Number of performance obligations Revenue, Number of Performance Obligations Revenue, Number of Performance Obligations Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Common stock, $0.0001 par value; 150,000,000 shares    authorized at March 31, 2023 and December 31, 2022, respectively;    60,716,873 and 60,578,956 shares issued and outstanding at March 31, 2023    and December 31, 2022, respectively Common Stock, Value, Issued Portion of outstanding term loan amount converted Debt Conversion, Original Debt, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Weighted Average Grant-Date Fair Value, Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Third Tranche Term Loan Third Tranche Term Loan [Member] Third tranche term loan. Conversion price per share (USD per share) Debt Instrument, Convertible, Conversion Price Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Capitalized Contract Cost [Domain] Capitalized Contract Cost [Domain] Private Placement Private Placement [Member] Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Series A One Redeemable Convertible Preferred Stock Series A One Redeemable Convertible Preferred Stock [Member] Series A one redeemable convertible preferred stock. Total future sublease payments Lessee Operating Sublease Receivables Due Lessee operating sublease receivables due. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Net income (loss) - basic Net Income (Loss) Available to Common Stockholders, Basic Common stock, issued (in shares) Common Stock, Shares, Issued Weighted Average Remaining Contractual Term (in years), Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Purchases of property and equipment included in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Income Statement Location [Domain] Income Statement Location [Domain] Transferred over Time Transferred over Time [Member] Convertible note payable, non-current Convertible Notes Payable, Noncurrent Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Non-cash operating lease cost Operating Lease, Cost Total principal payments Debt Instrument, Face Amount Interest expense on convertible note payable Interest on Convertible Debt, Net of Tax Issuance of common stock under stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Additional payments to be received Contract with Customer, Liability, Additional Payments to be Received Contract with Customer, Liability, Additional Payments to be Received Other assets Other Assets, Noncurrent Stock Option Activity, Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Number of Shares, options exercisable at June 30, 2022 (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Depreciation and amortization expense Depreciation, Depletion and Amortization Percentage of exercise price per share of stock options to fair market value of share of common stock (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Regulatory Milestone Payment Regulatory Milestone Payment [Member] Regulatory Milestone Payment Novartis Institutes for Biomedical Research, Inc. Novartis Institutes For Biomedical Research Inc [Member] Novartis Institutes for Biomedical Research, Inc. Issuance of common stock under stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Loan and Security Agreement Loan And Security Agreement [Member] Loan and security agreement. Additional Amounts Converted in Excess of $500 at $7.81 per share Additional Amounts Converted in Excess of $500,000 at $7.81 per share [Member] Additional Amounts Converted in Excess of $500,000 at $7.81 per share Number of shares of common stock converted under option plan (in shares) Number of Shares, outstanding beginning balance (in shares) Number of Shares, outstanding ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Number of positions, less then 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Clinical Milestone Payment Clinical Milestone Payment [Member] Clinical Milestone Payment Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property, Plant and Equipment, Net Transition Services Transition Services [Member] Transition Services Stock options to purchase common stock Share-Based Payment Arrangement, Option [Member] Title of Individual [Domain] Title of Individual [Domain] Gross proceeds from issuance of common stock Authorized Amount For Issuance Of Common Stock As Per Sales Agreement Authorized amount for issuance of common stock as per sales agreement. Notes Payable Notes Payable, Other Payables [Member] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Issuance of common stock upon exercise    of stock options Stock Issued During Period, Value, Stock Options Exercised Unvested restricted stock units, Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Other income, net Other Nonoperating Income (Expense) Common stock, authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total operating expenses Operating Expenses Maximum Maximum [Member] Second Tranche Term Loan Second Tranche Term Loan [Member] Second tranche term loan. Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Shares to be issued under the 2018 ESPP Share-Based Payment Arrangement [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Assets, Current Entity Small Business Entity Small Business Measurement Frequency [Domain] Measurement Frequency [Domain] Stockholders’ Equity Stockholders' Equity Note Disclosure [Text Block] Number of shares of common stock issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Summary of Financial Assets Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Non-cash interest expense related to note payable Noncash Interest Expense On Notes Payable Noncash interest expense on notes payable. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Sublease income Sublease Income Aggregate Intrinsic Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Title of 12(b) Security Title of 12(b) Security Final fee percentage (as a percent) Debt Instrument Final Fee Percentage Debt instrument final fee percentage. Debt Instrument [Line Items] Debt Instrument [Line Items] 2024 Lessee Operating Sublease Receivables Due Year One Lessee operating sublease receivables due year two. Number of option targets purchased Revenue, Performance Obligation, Number of Targets Purchased Revenue, Performance Obligation, Number of Targets Purchased Class of Stock [Line Items] Class of Stock [Line Items] Financing costs Payments of Debt Issuance Costs U.S. government agency bonds US Government Agencies Debt Securities [Member] Investments, Debt and Equity Securities [Abstract] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] U.S. Treasury notes US Treasury Securities [Member] Weighted Average Exercise Price, Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] 2023 Long-Term Debt, Maturity, Remainder of Fiscal Year K2 Health Ventures LLC K2 Health Ventures L L C [Member] K2 Health Ventures LLC. Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Sales Milestone Sales Milestone [Member] Sales Milestone Amount of cash from financing activities needed to extend interest-only period Debt Instrument, Term, Amount of Cash from Financing Activities Needed to Extend Interest-Only Period Debt Instrument, Term, Amount of Cash from Financing Activities Needed to Extend Interest-Only Period Accounts payable Accounts Payable, Current Comprehensive income (loss): Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other assets Increase (Decrease) in Other Operating Assets Aggregate Intrinsic Value, Vested and expected to vest at June 30, 2022 (In dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Summary of Available-for-sale Debt Securities by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Loan Amendment Loan Amendment [Member] Loan Amendment Nature of the Business Nature of Operations [Text Block] Entity Filer Category Entity Filer Category Net proceeds from issuance of common stock Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Weighted average common shares outstanding— basic (in shares) Weighted average commons shares outstanding—basic (shares) Weighted Average Number of Shares Outstanding, Basic Payment Occurs on or before Twenty Four Months after Initial Funding Date Payment Occurs On Or Before Twenty Four Months After Initial Funding Date [Member] Payment occurs on or before twenty four months after initial funding date. Stock-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies Commitments and Contingencies Security Exchange Name Security Exchange Name Weighted Average Exercise Price, Outstanding beginning balance (in dollars per share) Weighted Average Exercise Price, Outstanding ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price License License [Member] Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized    at March 31, 2023 and December 31, 2022; no shares    issued and outstanding at March 31, 2023 and December 31, 2022 Preferred Stock, Value, Issued General and administrative expenses General and Administrative Expense [Member] License-related revenue License related revenue Revenue from Contract with Customer, Excluding Assessed Tax Corporate bonds Corporate Bond Securities [Member] Capital common shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Number of votes entitled by each share of common stock holder Number Of Votes Entitled By Each Share Of Common Stock Holder Number of votes entitled by each share of common stock holder. Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Percentage of authorized number of shares of common stock outstanding (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Stock-Based Awards Share-Based Payment Arrangement [Text Block] Unbilled receivable Increase (Decrease) in Contract with Customer, Asset First Tranche Term Loan First Tranche Term Loan [Member] First tranche term loan. Total liabilities and stockholders’ equity Liabilities and Equity Term of the combined facility (months) Debt Instrument, Term Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Related Party [Axis] Related Party [Axis] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Dilutive effect of restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Diluted net income (loss) per share: Earnings Per Share, Diluted [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Inducement Plan Inducement Plan [Member] Inducement Plan Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amortized Cost Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract] Net income (loss) - diluted (in dollars per share) Net Income (Loss) Available to Common Stockholders, Diluted Vesting [Axis] Vesting [Axis] Net income (loss) per share — diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Sublease term Lessee, Operating Sublease, Term of Contract Lessee, Operating Sublease, Term of Contract Vesting August 2023 Share-Based Payment Arrangement, Tranche Two [Member] Proceeds from sales of property and equipment Proceeds from Sale of Property, Plant, and Equipment Stock options granted vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Total current liabilities Liabilities, Current Sublease extension term Lessee, Operating Sublease, Renewal Term Lessee, Operating Sublease, Renewal Term Entity Ex Transition Period Entity Ex Transition Period Amounts due from related party Due from Related Parties Stock options granted expiry period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Gross proceeds from issuance of preference stock Proceeds from Issuance of Preferred Stock and Preference Stock Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Product and Service [Axis] Product and Service [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Interest expense Interest Expense Aggregate Intrinsic Value, Options exercisable at June 30, 2022 (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Credit Facility [Axis] Credit Facility [Axis] Unrealized gain (loss) on marketable securities, net of tax of $0 Unrealized gain (loss) on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Capitalized Contract Cost [Axis] Capitalized Contract Cost [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Equity [Abstract] Equity [Abstract] Debt Conversion Description [Axis] Debt Conversion Description [Axis] Unvested restricted stock units, Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Upfront payment Contract with Customer, Upfront Payment Contract with Customer, Upfront Payment Entity Tax Identification Number Entity Tax Identification Number Number of shares of common stock to be issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Percentage of gross proceeds of shares sold for compensation (as a percent) Percentage Of Gross Proceeds Of Shares Sold For Compensation Percentage of gross proceeds of shares sold for compensation. Debt Conversion, Name [Domain] Debt Conversion, Name [Domain] Prepayment Occurs More than Twenty Four Months after, but on or before Thirty Six Months after Initial Funding Date Prepayment Occurs More Than Twenty Four Months After But On Or Before Thirty Six Months After Initial Funding Date [Member] Prepayment occurs more than twenty four months after, but on or before thirty six months after initial funding date. 2023 Lessee Operating Sublease Receivables Due Remainder Of Fiscal Year Lessee operating sublease receivables due remainder of fiscal year. Net increase (decrease) in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amortized Cost Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost Unaudited Interim Financial Information Unaudited Interim Financial Information Policy [Policy Text Block] Unaudited interim financial information. Schedule of Collaboration Revenue Schedule Of Collaboration Revenue [Table Text Block] Schedule of collaboration revenue related party. Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Weighted Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Collaboration and License Agreements Collaborative Arrangement Disclosure [Text Block] Percentage of share holding (as a percent) Percentage Of Share Holding By Related Party Percentage of share holding by related party. City Area Code City Area Code Debt instrument interest rate, floating (as a percent) Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate General and administrative General and Administrative Expense Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Fair Value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from issuance of common stock upon public offering, net Proceeds from Issuance Initial Public Offering 2024 Long-Term Debt, Maturity, Year One Supplemental disclosure of non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Weighted average grant-date fair value per share of stock options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Beneficial conversion feature Debt Instrument, Convertible, Beneficial Conversion Feature Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development expenses Research and Development Expense [Member] Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]